The Ubiquitous Human Skin Commensal Staphylococcus hominis Protects against Opportunistic Pathogens

被引:53
作者
Severn, Morgan M. [1 ]
Williams, Michael R. [2 ]
Shahbandi, Ali [4 ]
Bunch, Zoie L. [4 ]
Lyon, Laurie M. [1 ]
Nguyen, Amber [1 ]
Zaramela, Livia S. [3 ]
Todd, Daniel A. [4 ]
Zengler, Karsten [3 ,5 ,6 ]
Cech, Nadja B. [4 ]
Gallo, Richard L. [2 ,5 ]
Horswill, Alexander R. [1 ,7 ]
机构
[1] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA
[2] Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA
[4] Univ N Carolina, Dept Chem & Biochem, Greensboro, NC USA
[5] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA
[6] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA
[7] Colorado Healthcare Syst, Dept Vet Affairs Eastern, Aurora, CO 80045 USA
基金
美国国家卫生研究院;
关键词
Staphylococcus aureus; coagulase-negative staphylococci; quorum sensing; skin microbiota; AUREUS; AGR; EPIDERMIDIS; MICROBIOME; DIVERSIFICATION; IDENTIFICATION; COLONIZATION; INHIBITION; EMERGENCE; VIRULENCE;
D O I
10.1128/mbio.00930-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human skin is home to a variety of commensal bacteria, including many species of coagulase-negative staphylococci (CoNS). While it is well established that the microbiota as a whole maintains skin homeostasis and excludes pathogens (i.e., colonization resistance), relatively little is known about the unique contributions of individual CoNS species to these interactions. Staphylococcus hominis is the second most frequently isolated CoNS from healthy skin, and there is emerging evidence to suggest that it may play an important role in excluding pathogens, including Staphylococcus aureus, from colonizing or infecting the skin. Staphylococcus hominis is frequently isolated from human skin, and we hypothesize that it may protect the cutaneous barrier from opportunistic pathogens. We determined that S. hominis makes six unique autoinducing peptide (AIP) signals that inhibit the major virulence factor accessory gene regulator (agr) quorum sensing system of Staphylococcus aureus. We solved and confirmed the structures of three novel AIP signals in conditioned medium by mass spectrometry and then validated synthetic AIP activity against all S. aureus agr classes. Synthetic AIPs also inhibited the conserved agr system in a related species, Staphylococcus epidermidis. We determined the distribution of S. hominis agr types on healthy human skin and found S. hominis agr-I and agr-II were highly represented across subjects. Further, synthetic AIP-II was protective in vivo against S. aureus-associated dermonecrotic or epicutaneous injury. Together, these findings demonstrate that a ubiquitous colonizer of human skin has a fundamentally protective role against opportunistic damage. IMPORTANCE Human skin is home to a variety of commensal bacteria, including many species of coagulase-negative staphylococci (CoNS). While it is well established that the microbiota as a whole maintains skin homeostasis and excludes pathogens (i.e., colonization resistance), relatively little is known about the unique contributions of individual CoNS species to these interactions. Staphylococcus hominis is the second most frequently isolated CoNS from healthy skin, and there is emerging evidence to suggest that it may play an important role in excluding pathogens, including Staphylococcus aureus, from colonizing or infecting the skin. Here, we identified that S. hominis makes 6 unique peptide inhibitors of the S. aureus global virulence factor regulation system (agr). Additionally, we found that one of these peptides can prevent topical or necrotic S. aureus skin injury in a mouse model. Our results demonstrate a specific and broadly protective role for this ubiquitous, yet underappreciated skin commensal.
引用
收藏
页数:21
相关论文
共 82 条
[1]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[2]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[3]   Population genetic structure of the Staphylococcus intermedius group:: Insights into agr diversification and the emergence of methicillin-resistant strains [J].
Bannoehr, Jeanette ;
Ben Zakour, Nouri L. ;
Waller, Andrew S. ;
Guardabassi, Luca ;
Thoday, Keith L. ;
van den Broek, Adri H. M. ;
Fitzgerald, J. Ross .
JOURNAL OF BACTERIOLOGY, 2007, 189 (23) :8685-8692
[4]   Universal Dermal Microbiome in Human Skin [J].
Bay, Lene ;
Barnes, Christopher James ;
Fritz, Blaine Gabriel ;
Thorsen, Jonathan ;
Restrup, Marlene Elise Moller ;
Rasmussen, Linett ;
Sorensen, Johan Klovgaard ;
Hesselvig, Anne Brun ;
Odgaard, Anders ;
Hansen, Anders Johannes ;
Bjarnsholt, Thomas .
MBIO, 2020, 11 (01)
[5]   Coagulase-Negative Staphylococci [J].
Becker, Karsten ;
Heilmann, Christine ;
Peters, Georg .
CLINICAL MICROBIOLOGY REVIEWS, 2014, 27 (04) :870-926
[6]   Bile salt hydrolase activity in probiotics [J].
Begley, M ;
Hill, C ;
Gahan, CGM .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2006, 72 (03) :1729-1738
[7]   Keratinocytes as sensors and central players in the immune defense against Staphylococcus aureus in the skin [J].
Bitschar, Katharina ;
Wolz, Christiane ;
Krismer, Bernhard ;
Peschel, Andreas ;
Schittek, Birgit .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2017, 87 (03) :215-220
[8]   Identification of Genes Involved in Polysaccharide-Independent Staphylococcus aureus Biofilm Formation [J].
Boles, Blaise R. ;
Thoendel, Matthew ;
Roth, Aleeza J. ;
Horswill, Alexander R. .
PLOS ONE, 2010, 5 (04)
[9]   Staphylococcus epidermidis-Skin friend or foe? [J].
Brown, Morgan M. ;
Horswill, Alexander R. .
PLOS PATHOGENS, 2020, 16 (11)
[10]   Novel Peptide from Commensal Staphylococcus simulans Blocks Methicillin-Resistant Staphylococcus aureus Quorum Sensing and Protects Host Skin from Damage [J].
Brown, Morgan M. ;
Kwiecinski, Jakub M. ;
Cruz, Luis Mejia ;
Shahbandi, Ali ;
Todd, Daniel A. ;
Cech, Nadja B. ;
Horswill, Alexander R. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (06)